Skip to main content
Equibles
CPMV logo

CPMV · Mosaic ImmunoEngineering Inc. · Metrics

Track CPMV — free

Use CPMV with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research CPMV.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$0.33 At close · Oct 9
Rebalance outlook locked
Going-concern doubt — flagged Aug 14, 2026

Substantial doubt about the company's ability to continue as a going concern.

“The above matters raise substantial doubt regarding our ability to continue as a going concern.”
View the 10-Q filed Aug 14, 2026
Market Cap
$2.41M
Shares
7.24M
Volume · Oct 9 1700 Avg daily vol (3M) 1217

CPMV metrics

45 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$0.33
Market cap
$2.41M

Price action

20 metrics
Price change (1W)
+214.2%
Price change (30D)
+445.9%
Price change (3M)
-47.9%
Price change (6M)
-52.1%
Price change (YTD)
+7.1%
Price change (1Y)
-52.3%
Trailing year
Price change (5Y)
-77.8%
52-week high
$1.05
52-week low
$0.05
Change from 52-week high
-68.3%
Change from 52-week low
+516.7%
Annualized volatility
1,444.4%
Annualized volatility (3M)
—
Beta
—
RSI (14D)
52.9
Price vs SMA 50
-22.7%
Price vs SMA 200
-42.9%
Avg volume (3M)
1,217
Relative volume
1.4
Average dollar volume
$296

Company

3 metrics
Sector
Healthcare
Industry
Biotechnology
Shares outstanding
7.24M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
—
P / book
—
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-28.5%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
—

Profitability

9 metrics
Gross margin
—
Operating margin
—
Trailing 12 months
Net margin
—
Gross profit (TTM)
—
Operating profit (TTM)
−$604,014
Net income (TTM)
−$687,345
Trailing 12 months
Diluted EPS (TTM)
$-0.09
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$-1.03

Growth

11 metrics
Revenue growth YoY
—
Year over year
Net income growth YoY
—
Revenue (TTM)
—
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+0.0%
Year over year
Revenue CAGR (3Y)
—
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
—
Return on assets
-20,968.4%
Debt / equity
—
Current ratio
0.0
EBITDA (TTM)
—
Free cash flow (TTM)
—
Quick ratio
0.0
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
−$1.70M
Latest balance sheet
Cash & equivalents
$26
Total assets
$3,278
Total debt
$1.70M

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$53,557
Capital expenditures (TTM)
—
R&D (TTM)
$63,660
SG&A (TTM)
$996,019
Stock compensation (TTM)
$0
R&D / revenue
—
Stock compensation / revenue
—

Ownership (13F)

9 metrics
13F filers
—
13F filer change QoQ
—
Institutional ownership
—
Conviction holders (share of 13F filers)
—
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
—
Holder tenure
—
Price vs estimated holder cost
—

Ownership (registered funds)

1 metrics
Index-fund ownership
0.0%

Short interest

3 metrics
Short interest
0.0%
Latest settlement · 1.9 days to cover
Days to cover
1.9d
Short-squeeze score
17 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
Flagged
Key facts CIK 836564 CUSIP 61945M101 Visit website Investor relations